Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis M Aledort

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Epidemiology|November 19, 2002
Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York CityEric A Engels, Elizabeth Clark, Louis M Aledort, et al.
American Journal of Epidemiology|March 24, 2007
Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990James J Goedert, Bingshu E Chen, Liliana Preiss, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 7, 2011
An algorithmic approach to peripheral artery disease in hemophilia: extrapolation of management principles from noncoagulopathic patientsPatrick F Fogarty, Jeffrey W Olin, Craig M Kessler, et al.
American Journal of Hematology|June 30, 2004
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesLouis M Aledort, Catherine P M Hayward, Mon-Gy Chen, et al.
Thrombosis and Haemostasis|May 26, 2012
Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplastyJeffrey Bander, Sammy Elmariah, Louis M Aledort, et al.
Blood|May 8, 2014
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopeniaJames B Bussel, David J Kuter, Louis M Aledort, et al.
The New England Journal of Medicine|October 20, 2006
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITPJames B Bussel, David J Kuter, James N George, et al.
Blood|August 15, 2002
End-stage liver disease in persons with hemophilia and transfusion-associated infectionsJames J Goedert, M Elaine Eyster, Michael M Lederman, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Epidemiology|November 19, 2002
Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York CityEric A Engels, Elizabeth Clark, Louis M Aledort, et al.
American Journal of Epidemiology|March 24, 2007
Reconstruction of the hepatitis C virus epidemic in the US hemophilia population, 1940-1990James J Goedert, Bingshu E Chen, Liliana Preiss, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 7, 2011
An algorithmic approach to peripheral artery disease in hemophilia: extrapolation of management principles from noncoagulopathic patientsPatrick F Fogarty, Jeffrey W Olin, Craig M Kessler, et al.
American Journal of Hematology|June 30, 2004
Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodiesLouis M Aledort, Catherine P M Hayward, Mon-Gy Chen, et al.
Thrombosis and Haemostasis|May 26, 2012
Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplastyJeffrey Bander, Sammy Elmariah, Louis M Aledort, et al.
Blood|May 8, 2014
A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopeniaJames B Bussel, David J Kuter, Louis M Aledort, et al.
The New England Journal of Medicine|October 20, 2006
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITPJames B Bussel, David J Kuter, James N George, et al.
Blood|August 15, 2002
End-stage liver disease in persons with hemophilia and transfusion-associated infectionsJames J Goedert, M Elaine Eyster, Michael M Lederman, et al.
Lancet (London, England)|February 5, 2008
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trialDavid J Kuter, James B Bussel, Roger M Lyons, et al.
Pageof 4